This week on the podcast Agustin sits down with the Lynn Kirkpatrick the CEO of Ensysce Biosciences. Ensysce is an innovative company that is seeking to address the opioid crisis by leveraging advanced chemistry to prevent opioid abuse and ensure targeted and appropriate dosing of pain medications. Apart from opioids, Ensysce is looking to leverage their technology across a host of indications with the goal of making  drug delivery safer and more effective. 

If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com